Fate Therapeutics develops groundbreaking therapeutics using induced pluripotent stem cells (iPSCs) to create innovative cellular immunotherapies. Targeted at patients in need of advanced treatments, the company is leading the way in the manufacture and clinical development of off-the-shelf, engineered iPSC-derived cell products, offering multi-faceted solutions for various diseases.
